The global critical care diagnostics market size was valued at USD 1.17 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.9% from 2023 to 2030. The increasing prevalence of chronic diseases, including cardiovascular diseases, respiratory disorders, and cancer, has stimulated the... Read More »
September 2023The U.S. mobile physician practice market size was valued at USD 158.6 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.5% over the forecast period from 2023 to 2030. The market growth is attributed to factors such as the increasing incidence of chr... Read More »
September 2023The U.S. molecular diagnostics market size was estimated at USD 5.83 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.82% from 2023 to 2030. The increasing prevalence of infections and technological advancements in molecular diagnostic tests drive the ... Read More »
September 2023The global drug of abuse testing services market size was estimated at USD 6.33 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 3.91% by 2030. The market is witnessing growth due to factors such as emerging testing programs and escalating prevalence rat... Read More »
September 2023The global blood preparation market size was valued at USD 45.25 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.4% from 2023 to 2030. Growing incidence of blood-related disorders, rising number of transfusion procedures, and increasing donations are ... Read More »
September 2023The global helicobacter pylori diagnostics market size was estimated at USD 528.2 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.5% from 2023 to 2030. Increasing demand for personalized antibiotic therapy, rise in infectious diseases, improved cos... Read More »
September 2023The North America bloodstream infection testing market size was valued at USD 307.88 million in 2022 and is estimated to grow at a compound annual growth rate (CAGR) of 3.6% from 2023 to 2030. Increasing demand for advanced bloodstream infection testing methods and a rising number of CRO... Read More »
September 2023The global fluorescent in situ hybridization probe market size was estimated at USD 828.60 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 7.6% from 2023 to 2030. The growth of the market is attributed to factors, such as an increasing demand for in ... Read More »
September 2023The global self-testing market size was valued at USD 9.98 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.0% from 2023 to 2030. Self-test kits are used for the rapid diagnosis of a wide variety of illnesses. The growth of the market for self-tes... Read More »
September 2023The North America urinary tract infection testing market size was valued at USD 197.22 million in 2022 and is estimated to grow at a compound annual growth rate (CAGR) of 4.0% from 2023 to 2030. The increasing prevalence of Urinary Tract Infections (UTIs), the aging population, increasin... Read More »
September 2023The global in-vitro colorectal cancer screening tests market size was valued at USD 864.55 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 3.02% from 2023 to 2030. The growing prevalence of colon and rectal melanoma cases and increasing demand for effec... Read More »
September 2023The global newborn screening market size was valued at USD 789.35 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.54% from 2023 to 2030.The rising neonatal population, increasing cases of congenital diseases in newborns, growing consumer awareness, an... Read More »
September 2023The global women’s health diagnostics market size was estimated at USD 17.8 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2030. The rising prevalence of infectious diseases, such as hepatitis and urinary tract infection, amo... Read More »
September 2023The global HIV diagnostics market size was estimated at USD 985.7 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.5% over the forecast period owing to the technological development of disease diagnostic tests, and the anticipated development & ... Read More »
September 2023The global pharmacogenomics technology market size was estimated at USD 6.2 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 8.7% from 2023 to 2030. Advancements in genomics have led to an increased understanding of genetic variations and their impact... Read More »
September 2023The global ovarian cancer diagnostics market size was estimated at USD 1.2 billion in 2018 and is expected to grow at a CAGR of 6.2% during the forecast period. Rising prevalence of ovarian cancer and increasing emphasis on early diagnosis & treatment are expected to drive market gro... Read More »
August 2023The global lung cancer diagnostics market size was estimated at USD 1.63 billion in 2015. Technological advancements pertaining to tumor diagnosis contribute to market growth. The need for more efficient diagnostic systems is due to the fact that only 15% of the lung cancer cases get dia... Read More »
August 2023The U.S. non invasive prenatal testing market size was estimated at USD 1.60 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.18% from 2023 to 2030. The market’s growth can be attributed to the increasing average maternal age, rising incidence ... Read More »
August 2023The global next generation cancer diagnostics market size was estimated at USD 14.84 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 9.3% from 2023 to 2030. The growth is anticipated to be driven by the rising incidence of oncology diseases, the need f... Read More »
August 2023The global HPV testing and Pap test market size was estimated at USD 3.90 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.8% from 2023 to 2030. Technological advancements in testing products, the increasing prevalence of cervical cancer, and gov... Read More »
August 2023